Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / articles / CLRB - Cellectar Biosciences to Announce Top-line Data from WM Pivotal Trial on January 8 2024 | Benzinga

CLRB - Cellectar Biosciences to Announce Top-line Data from WM Pivotal Trial on January 8 2024 | Benzinga

Cellectar Biosciences Inc.

  • Management to host conference call on Monday, January 8, 2024, at 8:00 am ET

    Company also to present at the Biotech Showcase

    FLORHAM PARK, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced it will host a call detailing top-line data from its pivotal trial of iopofosine I 131 in Waldenstrom's macroglobulinemia on Monday, January 8, 2024 at 8:00 am ET. The company will also be presenting at the Biotech Showcase conference the following day. Details for each event are as follows:

    Top-line Conference call details:
    Date:
    Monday, January 8, 2024
    Time:
    8:00 am ET / 5:00 am PT
    Dial-in:
    1-888-886-7786
    Webcast Link:
    Click HERE


    Full story available on Benzinga.com
    Stock Information
    Company Name: Cellectar Biosciences Inc.
    Stock Symbol: CLRB
    Market: NASDAQ
    Website: cellectar.com
    Menu
    CLRB CLRB Quote CLRB Short CLRB News CLRB Articles CLRB Message Board
    Get CLRB Alerts

    News, Short Squeeze, Breakout and More Instantly...